|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/605 | |
| C07K 14/575 | |||
| C07K 14/62 | |||
| A61K 38/26 | |||
| A61K 38/22 | |||
| A61P 3/10 |
| (11) | Number of the document | 2590997 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11804451.0 |
| Date of filing the European patent application | 2011-07-08 | |
| (97) | Date of publication of the European application | 2013-05-15 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/043465 |
| Date | 2011-07-08 |
| (87) | Number | WO 2012/006598 |
| Date | 2012-01-12 |
| (30) | Number | Date | Country code |
| 363097 P | 2010-07-09 | US |
| (72) |
WALENSKY, Loren, D., US
BIRD, Gregory, US
|
| (73) |
Dana-Farber Cancer Institute, Inc.,
450 Brookline Avenue, Boston, MA 02215,
US
|
| (54) | STABILIZED INSULINOTROPIC PEPTIDES AND METHODS OF USE |
| STABILIZED INSULINOTROPIC PEPTIDES AND METHODS OF USE |